ArticleClinicoEconomics and outcomes research : CEOR2018

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C.

Katherine HeathPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.